Zhejiang Jingxin Pharmaceutical Co., Ltd.

¥12.31As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002020Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 4.34%
Div yield 2.84%
ROE 12.66%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.10)
PE TTM 13.84
TSR TTM (32.79%)
Mkt cap ¥10.11B
ROIC 14.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
(2.34%)
(73.57%)
Hold 9|11|12|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.30
0.31
0.31
0.34
36.54%
25.27%
13.76%
25.80%
Revenue¥M
609.8
596.8
612.5
610.0
17.84%
9.91%
10.84%
4.43%
Peers (US$1.515B)
Cap (US$)
PE
1.503B
343.0x
Capital
TTM
5Y
10Y
Leveragex
0.407
0.732
0.555
EBIT/Intx
2.911
0.388
0.366
Own earn%
194.99
(61.62)
(40.19)
Sh yield%
35.87
14.86
14.06
Owners
Insiders/Inst%
8.15
69.46
Short interest%
2.05
SBC / revenue%
3.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
17–26
$1 testx
—
Incr. ROIC%
1